RESCHEDULED: Examining Concerns Regarding FDA's Proposed Changes to Generic Drug Labeling

Tuesday, April 1, 2014 - 3:00pm
2322 Rayburn
Background Documents and Information: 
Witnesses: 

Panel I

 

Janet Woodcock, M.D.,

Panel II

 

Michael D. Shumsky

Ralph G. Neas

Allison M. Zieve

Congress: